Back to Search Start Over

Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students—Iowa, 2006

Authors :
Marin, Mona
Quinlisk, Patricia
Shimabukuro, Tom
Sawhney, Charu
Brown, Cedric
LeBaron, Charles W.
Source :
Vaccine. Jul2008, Vol. 26 Issue 29/30, p3601-3607. 7p.
Publication Year :
2008

Abstract

Abstract: Following implementation of a routine childhood two-dose measles–mumps–rubella vaccination strategy, mumps disease levels dropped dramatically in the US and an elimination goal was set for 2010. However, a 2006 epidemic involved >5700 cases nationwide, with many reported among fully vaccinated college students. In an outbreak in two Iowa colleges, we investigated: (1) vaccination coverage using electronic records verified by provider records and (2) vaccine effectiveness assessed by comparison of dose-specific attack rates. Mumps was classified as typical (parotitis/orchitis) or atypical (parotid tenderness or submandibular/sublingual adenitis). Two-dose mumps vaccination coverage was 90% both for the student population (2128/2363) and case-students (97/108). Two-dose vaccine effectiveness was 76–88% with no significant difference for attack rates between one and two doses. Among two-dose vaccine recipients, 74% of the population (1482/2009) and 79% of the case-students (75/95) had received the second dose >10 years before. A large mumps outbreak occurred despite high two-dose vaccination coverage in a population most of whom had received the second dose >10 years before. Two-dose vaccine effectiveness was similar to previous one-dose estimates. Further studies are needed to examine the persistence of two-dose mumps vaccine-induced immunity and to determine whether US mumps elimination can be achieved with the current vaccination strategy. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
0264410X
Volume :
26
Issue :
29/30
Database :
Academic Search Index
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
32736289
Full Text :
https://doi.org/10.1016/j.vaccine.2008.04.075